Post-Marketing Surveillance Study on NesinaAct Tablet Use Among Type 2 Diabetes Mellitus Patients in Korea
Latest Information Update: 09 Mar 2022
At a glance
- Drugs Alogliptin/pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Takeda
- 04 Aug 2021 New trial record